CLASSYS Inc.
214150.KQ
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.98T
Close$
$85619.32
207.4% upside
Current Fair Value
207.4% upsideUndervalued by 207.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.98 Trillion |
|---|---|
| Enterprise Value | $2.05 Trillion |
| Dividend Yield | $257.00 (0.85%) |
| Earnings per Share | $2013.57 |
| Beta | 0.56 |
| Outstanding Shares | 65,220,000 |
Return
| Return on Equity | 25.05% |
|---|---|
| Return on Assets | 17.76% |
| Return on Invested Capital | 30.51% |
Valuation & Multiples
| P/E Ratio | 14.41 |
|---|---|
| PEG | 197.78 |
| Price to Sales | 4.92 |
| Price to Book Ratio | 3.27 |
| Enterprise Value to Revenue | 5.55 |
| Enterprise Value to EBIT | 11.66 |
| Enterprise Value to Net Income | 14 |
| Total Debt to Enterprise | 0.07 |
| Debt to Equity | 0.27 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 14, 2026
EPS Estimate
$493.88
Average shareholder expectationRevenue Estimate
$107.20 B
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$512.85
Average shareholder expectationRevenue Estimate
$114.45 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About CLASSYS Inc.
527 employees
CEO: Seung-Han Baek CLASSYS Inc. is a global supplier of sophisticated medical aesthetic devices. Its diverse product range features SCIZER, a non-invasive solution for subcutaneous fat reduction; ULTRAFORMER MPT, which employs focused ultrasound stimulatio...